Beyond the Driver Mutation: Immunotherapies in Gastrointestinal Stromal Tumors

by Matthieu Roulleaux Dugage, Robin Lewis Jones, Jonathan Trent, Stéphane Champiat, Sarah Dumont
Published 2021-08-01

256 Single-agent zalifrelimab (anti-CTLA-4) shows clinical benefit in rare tumors – case report from phase 2 study (NCT03104699)

by Hong Zhang, Robert Wesolowski, Cesar Perez, Breelyn Wilky, Waldo Ortuzar Feliu, Remigiusz Kaleta, Jonathan Trent
Published 2020-11-01

CIC-rearranged round cell (Ewing-like) sarcoma of the uterus: Review of the literature

by Shaina Sedighim, Jonathan Burke, Douglas Schneider, Talia Kamdjou, Julio A. Diaz-Perez, Jonathan Trent, Mecker Möller
Published 2020-08-01

Case report: The activity of multi-kinase VEGF inhibitor, Pazopanib, in metastatic undifferentiated round cell sarcomas harboring EWSR1::CREM fusion: clinicopathological series of...

by Leticia Campoverde, Leticia Campoverde, Felipe Camacho, Felipe Camacho, Francesco Alessandrino, Mark G. Evans, Andrew Elliot, Andrew Rosenberg, Jonathan Trent
Published 2023-09-01

Pathologic Response Rates after Neoadjuvant Therapy for Sarcoma: A Single Institution Study

by Crystal Seldon, Gautam Shrivastava, Melanie Fernandez, John Jarboe, Sheila Conway, Juan Pretell, Laura Freedman, Aaron Wolfson, Wei Zhao, Deukwoo Kwon, Andrew Rosenberg, Ty Subhawong, Jonathan Trent, Raphael Yechieli
Published 2021-03-01

The efficacies and biomarker investigations of anti-programmed death-1 (anti-PD-1)-based therapies for metastatic bone and soft tissue sarcoma

by Jia Lu, Ting Li, Zhichao Liao, Hui Yu, Yongtian Zhao, Haixiao Wu, Zhiwu Ren, Jun Zhao, Ruwei Xing, Sheng Teng, Yun Yang, Xiangchun Li, Kexin Chen, Jonathan Trent, Jilong Yang
Published 2022-06-01

What Is a Sarcoma ‘Specialist Center’? Multidisciplinary Research Finds an Answer

by Roger Wilson, Denise Reinke, Gerard van Oortmerssen, Ornella Gonzato, Gabriele Ott, Chandrajit P. Raut, B. Ashleigh Guadagnolo, Rick L. M. Haas, Jonathan Trent, Robin Jones, Lauren Pretorius, Brandi Felser, Mandy Basson, Kathrin Schuster, Bernd Kasper
Published 2024-05-01

Rationale and design of ON-TRK: a novel prospective non-interventional study in patients with TRK fusion cancer treated with larotrectinib

by James C. H. Yang, Marcia S. Brose, Gilberto Castro, Edward S. Kim, Ulrik N. Lassen, Serge Leyvraz, Alberto Pappo, Fernando López-Ríos, John A. Reeves, Marc Fellous, Frédérique Penault-Llorca, Erin R. Rudzinski, Ghazaleh Tabatabai, Gilles Vassal, Alexander Drilon, Jonathan Trent
Published 2022-06-01

Real-world pan-cancer landscape of frameshift mutations and their role in predicting responses to immune checkpoint inhibitors in cancers with low tumor mutational burden

by Ignacio Garrido-Laguna, Asaf Maoz, Wungki Park, Abdul Rafeh Naqash, Vaia Florou, Breelyn Wilky, Jonathan Trent, Umang Swami, Garrett Frampton, Heloisa P Soares, Sonam Puri, Aik Choon Tan, Charalampos S Floudas, Carter Norton, Ethan S Sokol, Peter Hosein, Gilberto de Lima Lopes
Published 2023-08-01

Unmet Medical Needs and Future Perspectives for Leiomyosarcoma Patients—A Position Paper from the National LeioMyoSarcoma Foundation (NLMSF) and Sarcoma Patients EuroNet (SPAEN)

by Bernd Kasper, Annie Achee, Kathrin Schuster, Roger Wilson, Gerard van Oortmerssen, Rebecca A. Gladdy, Matthew L. Hemming, Paul Huang, Matthew Ingham, Robin L. Jones, Seth M. Pollack, Denise Reinke, Roberta Sanfilippo, Scott M. Schuetze, Neeta Somaiah, Brian A. Van Tine, Breelyn Wilky, Scott Okuno, Jonathan Trent
Published 2021-02-01